PRLR-specific antibody and uses thereof
US9005614B2 · kind B2 · utility
5Cited by
51References
24Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 22, 2010 |
| Grant date | Apr 14, 2015 |
| Priority date | — |
| Expiry date | Feb 13, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/72
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
PRLR-specific antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.